These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22228203)
21. Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes. Rotroff DM; Pijut SS; Marvel SW; Jack JR; Havener TM; Pujol A; Schluter A; Graf GA; Ginsberg HN; Shah HS; Gao H; Morieri ML; Doria A; Mychaleckyi JC; McLeod HL; Buse JB; Wagner MJ; Motsinger-Reif AA; Clin Pharmacol Ther; 2018 Apr; 103(4):712-721. PubMed ID: 28736931 [TBL] [Abstract][Full Text] [Related]
22. Expression and Sequence Variants of Inflammatory Genes; Effects on Plasma Inflammation Biomarkers Following a 6-Week Supplementation with Fish Oil. Cormier H; Rudkowska I; Lemieux S; Couture P; Vohl MC Int J Mol Sci; 2016 Mar; 17(3):375. PubMed ID: 26999109 [TBL] [Abstract][Full Text] [Related]
23. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose. Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927 [TBL] [Abstract][Full Text] [Related]
24. Effects of fenofibrate on lipoproteins, vasomotor function, and serological markers of inflammation, plaque stabilization, and hemostasis. Kon Koh K; Yeal Ahn J; Hwan Han S; Kyu Jin D; Sik Kim H; Cheon Lee K; Kyun Shin E; Sakuma I Atherosclerosis; 2004 Jun; 174(2):379-83. PubMed ID: 15136070 [TBL] [Abstract][Full Text] [Related]
25. The SCARB1 gene is associated with lipid response to dietary and pharmacological interventions. Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK J Hum Genet; 2008; 53(8):709-717. PubMed ID: 18542840 [TBL] [Abstract][Full Text] [Related]
26. Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. Kowalski J; Okopien B; Madej A; Zielinski M; Belowski D; Kalina Z; Herman ZS Int J Clin Pharmacol Ther; 2003 Jun; 41(6):241-7. PubMed ID: 12816176 [TBL] [Abstract][Full Text] [Related]
27. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. Sebestjen M; Keber I; Zegura B; Simcic S; Bozic M; Fressart MM; Stegnar M Thromb Haemost; 2004 Nov; 92(5):1129-35. PubMed ID: 15543343 [TBL] [Abstract][Full Text] [Related]
28. Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study. Veenstra J; Kalsbeek A; Westra J; Disselkoen C; Smith C; Tintle N Nutrients; 2017 Aug; 9(8):. PubMed ID: 28820441 [TBL] [Abstract][Full Text] [Related]
29. Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass. Ouk T; Amr G; Azzaoui R; Delassus L; Fossaert E; Tailleux A; Bordet R; Modine T Vascul Pharmacol; 2016 May; 80():59-66. PubMed ID: 26779598 [TBL] [Abstract][Full Text] [Related]
30. Serum Carotenoids Are Inversely Associated with RBP4 and Other Inflammatory Markers in Middle-Aged and Elderly Adults. Jing L; Xiao M; Dong H; Lin J; Chen G; Ling W; Chen Y Nutrients; 2018 Feb; 10(3):. PubMed ID: 29495330 [TBL] [Abstract][Full Text] [Related]
31. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. Gervois P; Kleemann R; Pilon A; Percevault F; Koenig W; Staels B; Kooistra T J Biol Chem; 2004 Apr; 279(16):16154-60. PubMed ID: 14764586 [TBL] [Abstract][Full Text] [Related]
32. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Krysiak R; Gdula-Dymek A; Okopien B Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):198-202. PubMed ID: 22935083 [TBL] [Abstract][Full Text] [Related]
33. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. Naitza S; Porcu E; Steri M; Taub DD; Mulas A; Xiao X; Strait J; Dei M; Lai S; Busonero F; Maschio A; Usala G; Zoledziewska M; Sidore C; Zara I; Pitzalis M; Loi A; Virdis F; Piras R; Deidda F; Whalen MB; Crisponi L; Concas A; Podda C; Uzzau S; Scheet P; Longo DL; Lakatta E; Abecasis GR; Cao A; Schlessinger D; Uda M; Sanna S; Cucca F PLoS Genet; 2012 Jan; 8(1):e1002480. PubMed ID: 22291609 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. Wang TD; Chen WJ; Lin JW; Cheng CC; Chen MF; Lee YT Atherosclerosis; 2003 Oct; 170(2):315-23. PubMed ID: 14612213 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic interaction between simvastatin and fenofibrate with staggered and simultaneous dosing: Does it matter? Winsemius A; Ansquer JC; Olbrich M; van Amsterdam P; Aubonnet P; Beckmann K; Driessen S; van Assche H; Piskol G; Lehnick D; Mihara K J Clin Pharmacol; 2014 Sep; 54(9):1038-47. PubMed ID: 24691799 [TBL] [Abstract][Full Text] [Related]
36. Detecting responses to treatment with fenofibrate in pedigrees. Cherlin S; Wang MH; Bickeböller H; Cantor RM BMC Genet; 2018 Sep; 19(Suppl 1):64. PubMed ID: 30255820 [TBL] [Abstract][Full Text] [Related]
37. Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1β, and TNFα levels in type 2 diabetes and insulin resistance. Degirmenci I; Ozbayer C; Kebapci MN; Kurt H; Colak E; Gunes HV Inflamm Res; 2019 Sep; 68(9):801-814. PubMed ID: 31222667 [TBL] [Abstract][Full Text] [Related]
38. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. Danik JS; Paré G; Chasman DI; Zee RY; Kwiatkowski DJ; Parker A; Miletich JP; Ridker PM Circ Cardiovasc Genet; 2009 Apr; 2(2):134-41. PubMed ID: 20031577 [TBL] [Abstract][Full Text] [Related]
39. The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study. Shirinsky I; Polovnikova O; Kalinovskaya N; Shirinsky V Rheumatol Int; 2013 Dec; 33(12):3045-8. PubMed ID: 23263548 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance. Krysiak R; Gdula-Dymek A; Okopień B Pharmacol Rep; 2013; 65(2):429-34. PubMed ID: 23744427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]